Product Code: ETC323140 | Publication Date: Aug 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The UAE drug discovery services market is experiencing significant growth, driven by increasing investments in research and development. Pharmaceutical companies and biotechnology firms in the UAE are actively seeking innovative drug discovery solutions to address a wide range of diseases and medical conditions. This market offers promising opportunities for companies providing drug discovery services, including contract research organizations (CROs) and academic institutions.
The UAE Drug Discovery Services market is primarily driven by the increasing investment in healthcare and pharmaceutical research. As the country strives to become a leading player in the pharmaceutical industry, there is a growing demand for specialized drug discovery services. Factors such as the aging population, prevalence of chronic diseases, and government initiatives further stimulate this market.
The UAE Drug Discovery Services Market confronts the need for substantial investment in cutting-edge technology and research infrastructure to remain competitive. Attracting and retaining top-tier scientific talent poses a challenge, as global competition for skilled researchers intensifies. Regulatory compliance and intellectual property protection require meticulous attention, adding complexity to the drug development process. Additionally, navigating complex partnerships and collaborations in the biopharmaceutical ecosystem demands adept negotiation and management skills from market players.
The UAE drug discovery services market involves the outsourcing of research and development activities in the pharmaceutical and biotechnology sectors. COVID-19 led to an increased focus on vaccine and treatment development, driving demand for drug discovery services. The market saw growth as pharmaceutical companies sought expertise and resources to expedite their research efforts.
The drug discovery services market in the UAE is a growing sector in pharmaceutical research and development. Key players include Charles River Laboratories, Covance, and Eurofins Scientific.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Drug Discovery Services Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Drug Discovery Services Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Drug Discovery Services Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United Arab Emirates (UAE) Drug Discovery Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Drug Discovery Services Market Trends |
6 United Arab Emirates (UAE) Drug Discovery Services Market, By Types |
6.1 United Arab Emirates (UAE) Drug Discovery Services Market, By Process |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Process, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Target Selection, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Target Validation, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Hit-to-Lead identification, 2021-2031F |
6.1.6 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Lead Optimization, 2021-2031F |
6.1.7 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Candidate Validation, 2021-2031F |
6.2 United Arab Emirates (UAE) Drug Discovery Services Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Chemistry Services, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Biology Services, 2021-2031F |
6.3 United Arab Emirates (UAE) Drug Discovery Services Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Academic Institutes, 2021-2031F |
6.3.4 United Arab Emirates (UAE) Drug Discovery Services Market Revenues & Volume, By Others, 2021-2031F |
7 United Arab Emirates (UAE) Drug Discovery Services Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Drug Discovery Services Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Drug Discovery Services Market Imports from Major Countries |
8 United Arab Emirates (UAE) Drug Discovery Services Market Key Performance Indicators |
9 United Arab Emirates (UAE) Drug Discovery Services Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Drug Discovery Services Market Opportunity Assessment, By Process, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Drug Discovery Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Drug Discovery Services Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United Arab Emirates (UAE) Drug Discovery Services Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Drug Discovery Services Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Drug Discovery Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |